These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 38419562)

  • 1. Elevated INHBA Promotes Tumor Progression of Cervical Cancer.
    Wu Z; Chen J; Yang L; Sun K; Jiang Q; Dong F; Lu W; Chen R; Chen Y
    Technol Cancer Res Treat; 2024; 23():15330338241234798. PubMed ID: 38419562
    [No Abstract]   [Full Text] [Related]  

  • 2. Upregulation of TTYH3 promotes epithelial-to-mesenchymal transition through Wnt/β-catenin signaling and inhibits apoptosis in cholangiocarcinoma.
    Xue W; Dong B; Zhao Y; Wang Y; Yang C; Xie Y; Niu Z; Zhu C
    Cell Oncol (Dordr); 2021 Dec; 44(6):1351-1361. PubMed ID: 34796468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High expression of PTPRM predicts poor prognosis and promotes tumor growth and lymph node metastasis in cervical cancer.
    Liu P; Zhang C; Liao Y; Liu J; Huang J; Xia M; Chen M; Tan H; He W; Xu M; Liu T; Ooi S; Du Q; Qin S; Zhu Y; Zou Q; Wang W; Yao S
    Cell Death Dis; 2020 Aug; 11(8):687. PubMed ID: 32826853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GSG2 knockdown suppresses cholangiocarcinoma progression by regulating cell proliferation, apoptosis and migration.
    Zhou J; Nie W; Yuan J; Zhang Z; Mi L; Wang C; Huang R
    Oncol Rep; 2021 Jun; 45(6):. PubMed ID: 33846801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix metalloproteinase-2 inducing COL1A1 synthesis via integrin alpha Ⅴ promotes invasion and metastasis of cholangiocarcinoma cells.
    Pan S; Hu Y; Gan L; Lai J; Zheng P; Zhang Y; Shuai L; Jiang Y; Chen M; Wang J; He Y
    Ann Hepatol; 2024; 29(2):101279. PubMed ID: 38123132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNA CCAT2 promotes cholangiocarcinoma cells migration and invasion by induction of epithelial-to-mesenchymal transition.
    Xu Y; Yao Y; Qin W; Zhong X; Jiang X; Cui Y
    Biomed Pharmacother; 2018 Mar; 99():121-127. PubMed ID: 29329034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MORC2 promotes cell growth and metastasis in human cholangiocarcinoma and is negatively regulated by miR-186-5p.
    Liao G; Liu X; Wu D; Duan F; Xie X; Wen S; Li Y; Li S
    Aging (Albany NY); 2019 Jun; 11(11):3639-3649. PubMed ID: 31180332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibin subunit beta A promotes cell proliferation and metastasis of breast cancer through Wnt/β-catenin signaling pathway.
    Xueqin T; Jinhong M; Yuping H
    Bioengineered; 2021 Dec; 12(2):11567-11575. PubMed ID: 34889158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-494-dependent WDHDI inhibition suppresses epithelial-mesenchymal transition, tumor growth and metastasis in cholangiocarcinoma.
    Liu B; Hu Y; Qin L; Peng XB; Huang YX
    Dig Liver Dis; 2019 Mar; 51(3):397-411. PubMed ID: 30314946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FUT4 promotes the progression of Cholangiocarcinoma by modulating epithelial-mesenchymal transition.
    Liu E; Qian X; He Y; Chen K
    Cell Cycle; 2024 Jan; 23(2):218-231. PubMed ID: 38466946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA HOTAIR promotes tumorigenesis and forecasts a poor prognosis in cholangiocarcinoma.
    Qin W; Kang P; Xu Y; Leng K; Li Z; Huang L; Gao J; Cui Y; Zhong X
    Sci Rep; 2018 Aug; 8(1):12176. PubMed ID: 30111807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The LIN28B/TGF-β/TGFBI feedback loop promotes cell migration and tumour initiation potential in cholangiocarcinoma.
    Puthdee N; Sriswasdi S; Pisitkun T; Ratanasirintrawoot S; Israsena N; Tangkijvanich P
    Cancer Gene Ther; 2022 May; 29(5):445-455. PubMed ID: 34548635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Yin Yang 1-induced LINC00667 up-regulates pyruvate dehydrogenase kinase 1 to promote proliferation, migration and invasion of cholangiocarcinoma cells by sponging miR-200c-3p.
    Li J; Guan C; Hu Z; Liu L; Su Z; Kang P; Jiang X; Cui Y
    Hum Cell; 2021 Jan; 34(1):187-200. PubMed ID: 33040228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Up-regulated LINC00261 predicts a poor prognosis and promotes a metastasis by EMT process in cholangiocarcinoma.
    Gao J; Qin W; Kang P; Xu Y; Leng K; Li Z; Huang L; Cui Y; Zhong X
    Pathol Res Pract; 2020 Jan; 216(1):152733. PubMed ID: 31812439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LINC00844 suppresses tumor progression and predicts survival outcomes through inhibiting miR-19a-5p in cholangiocarcinoma.
    Zhang L; Jiang G; Lu J; Wang L
    Clin Transl Oncol; 2024 Feb; 26(2):414-423. PubMed ID: 37400667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of E-cadherin promotes migration and invasion of cholangiocarcinoma cells and serves as a potential marker of metastasis.
    Techasen A; Loilome W; Namwat N; Khuntikeo N; Puapairoj A; Jearanaikoon P; Saya H; Yongvanit P
    Tumour Biol; 2014 Sep; 35(9):8645-52. PubMed ID: 24867095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in chemokine receptor CCR5 activity influence tumor cell biology in human cholangiocarcinoma cell lines.
    Yang J; Sontag D; Gong Y; Minuk GY
    Ann Hepatol; 2021; 21():100265. PubMed ID: 33045415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BMI1 promotes cholangiocarcinoma progression and correlates with antitumor immunity in an exosome-dependent manner.
    Liu Z; Hu C; Zheng L; Liu J; Li K; Li X; Wang Y; Mu W; Chen T; Shi A; Qiu B; Zhang X; Zhang Z; Xu Y
    Cell Mol Life Sci; 2022 Aug; 79(9):469. PubMed ID: 35932322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MCM2 promotes the proliferation, migration and invasion of cholangiocarcinoma cells by reducing the p53 signaling pathway.
    Wang CL; Liu XY; Wang YH; Zhang Z; Wang ZD; Zhou GQ
    Yi Chuan; 2022 Mar; 44(3):230-244. PubMed ID: 35307646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EGF/EGFR axis contributes to the progression of cholangiocarcinoma through the induction of an epithelial-mesenchymal transition.
    Clapéron A; Mergey M; Nguyen Ho-Bouldoires TH; Vignjevic D; Wendum D; Chrétien Y; Merabtene F; Frazao A; Paradis V; Housset C; Guedj N; Fouassier L
    J Hepatol; 2014 Aug; 61(2):325-32. PubMed ID: 24704591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.